Study Identifies New Heart Risk Factors for SLE Women
Effective Treatment of SLE-Linked Macrophage Activation Syndrome
Fate Therapeutics' FT819 Receives FDA RMAT Designation
A recent study highlights the potential of a new...
This week's must-know community updates, latest research & events
Apply now: feature your voice in our cell and gene therapy series
Obinutuzumab Shows Success in Phase 3 Lupus Nephritis Trial
Hormone therapy linked to increased SLE risk
Study Finds Predictors for Successfully Stopping Steroid Use in Lupus Patients
Rare Coexistence: Patient Diagnosed with Both Lupus and Type II Cryoglobulinemia
